Awards will support risk-benefit analysis of COVID vaccination in kids A newly funded project will evaluate how risk communication for vaccines can be improved to boost vaccine uptake among children.
COVID rate at least double official figures: Antibody study At least 17% of Australians may have contracted COVID-19 during the first Omicron wave, new research suggests – and the true figure could be even higher.
Australian childhood cancer survival rates continue to improve More than 1500 deaths in children under 15 have been potentially avoided thanks to new treatments combined with better supportive care.
Influenza ‘resurgence’ expected in coming months Open borders and low immunity levels has added additional importance to year’s flu vaccine rollout, the Federal Health Secretary has written.
Boosters’ Omicron impact outlined in vaccination tool update GPs and patients can now generate personalised information on the risks and benefits associated with choosing whether or not to receive a booster shot.
How long should children wait to be vaccinated after COVID infection? COVID-19 vaccination for young children began at the same time as a spike in infections. Here is the most recent guidance available for GPs.
‘Dangerously off-track’: Call for global vaccine equity boost Omicron’s rise highlights the risks posed to Australia by world vaccination gaps, a high-profile group said in a letter to the Prime Minister.
WHO gives warning on missed measles vaccinations Measles vaccination has fallen sharply globally, but Australian immunisation rates appear to have held up despite the challenges of COVID-19.
Under-12s will not be vaccinated against COVID-19 until 2022 The TGA is waiting for more data before it decides whether to approve the Pfizer vaccine for children aged 5–11.
‘A complex decision’: COVID-19 vaccination and younger children The rollout of Pfizer for children aged 5–11 has been given the green light in the US. What is that likely to mean for vaccinators in Australia?